Stay updated on Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now displayed, replacing Revision: v3.6.3. This update seems to be a site version update rather than a substantive change to the study information.
    Difference
    0.0%
    Check dated 2026-07-25T05:27:57.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now displayed, replacing Revision: v3.6.2. This indicates a version update for the page/system rather than a content addition or removal.
    Difference
    0.0%
    Check dated 2026-07-03T21:46:38.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.6.2 replaces v3.6.0 on the page, representing a minor update to the page's version tag. It does not change the displayed study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-06-26T19:38:36.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page adds sections for No longer looking for participants, How to Read a Study Record, Common Questions, and How to Join a Study, and adjusts the Intervention/Treatment heading; it also removes the old Intervention / Treatment heading and old Revision label while adding Revision: v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T12:25:31.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    A new page revision tag, v3.5.5, was added, replacing the previous v3.5.4. This reflects a minor platform update without changing study details or visible content.
    Difference
    0.0%
    Check dated 2026-06-05T09:58:22.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page now shows a new revision label, Revision: v3.5.4, replacing the previous v3.5.3, indicating an internal update to the page version without changing publicly visible study information.
    Difference
    0.0%
    Check dated 2026-05-14T23:13:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Eribulin in HR+/HER2- MBC Clinical Trial page.